Applications

Tsingke delivers high-quality primers, probes, and custom oligonucleotides for qPCR, digital PCR, hybridization assays, and pathogen detection.

Our precise synthesis and rigorous QC ensure high sensitivity and specificity, supporting applications in infectious disease testing, genetic screening, oncology diagnostics, and veterinary health.

From antigen-encoding DNA and mRNA synthesis to vector design and protein expression, Tsingke provides a complete platform for vaccine R&D.

We support projects from early-stage construct design to GMP-grade production for clinical trials, with optional LNP formulation for mRNA vaccines.

Tsingke supplies sgRNA, crRNA, tracrRNA, and donor templates (ssODN, dsDNA) for CRISPR/Cas and other genome editing platforms.

Our high-fidelity synthesis and dual verification (Sanger + NGS) ensure precise targeting and high editing efficiency, enabling applications in functional genomics and therapeutic development.

We offer GMP-ready gene synthesis, vector construction, and nucleic acid production for therapeutic applications.

With capabilities in mRNA, saRNA, circRNA, and viral vector backbones, Tsingke supports the development of advanced therapies for rare diseases, oncology, and regenerative medicine — all under strict regulatory compliance.

Tsingke enables the design and production of genetic tools for crop improvement, livestock breeding, and pathogen detection in agricultural systems.

Our solutions include gene constructs for trait engineering, molecular markers, and diagnostic probes for plant and animal health monitoring.

We offer GMP-ready gene synthesis, vector construction, and nucleic acid production for therapeutic applications. With capabilities in mRNA,saRNA, circRNA, and viralvector backbones, Tsingke supports the development of advanced therapies for rare diseases, oncology, and regenerative medicine - all under strict regulatory compliance.